Anesthesia for Ventricular Assist Device Placement in Pediatric Patients: Experience From a Single Center

Basit Öğe Kaydı
dc.contributor.authorKocabas, S.
dc.contributor.authorAskar, F. Z.
dc.contributor.authorYagdi, T.
dc.contributor.authorEngin, C.
dc.contributor.authorOzbaran, M.
dc.date.accessioned2019-10-27T21:52:30Z
dc.date.available2019-10-27T21:52:30Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description9th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- SEP 26-29, 2012 -- Bursa, TURKEYen_US
dc.description.abstractBackground. The use of a ventricular assist device (VAD) as a bridge to heart transplantation in the pediatric population has evolved over the past decades This article presents our institution's clinical experience in the anesthetic management of pediatric patients with end-stage heart failure who underwent implantation of a VAD between June 2009 and August 2012. Methods. Between February 2011 and August 2012, implantation of a VAD was performed in 10 children of mean age 8.6 years. This retrospective review analyzed their perioperative anesthetic care. Results. All patients had end-stage heart failure due to dilated cardiomyopathy. We used invasive arterial and central venous pressure monitoring and intraoperative transesophageal echocardiography in conjunction with intravenous administration of either ketamine (1 mg/kg) and midazolam (n = 3) or thiopental (3-5 mg/kg; n = 7). The mean intraoperative fentanyl dose was 434 +/- 264.27 mu g. Anesthesia was maintained with sevoflurane. Dopamine, dobutamine, and epinephrine were infused in 8, 10, and 5 patients, respectively. Inhaled nitric oxide was administered to all patients. The amounts of perioperative blood, fresh frozen plasma, and thrombocyte suspension transfusions were be 2.3 +/- 0.82 (range, 1-4), 1.6 +/- 0.69 (range, 1-3), and 2.4 +/- 1.42 (range, 0-4) units, respectively. On average, patients were extubated 23 hours after arrival in the intensive care unit and exited there on day 6. Six patients were successfully bridged to heart transplantation, 2 died during the follow-up, and 2 patients remain on VAD support. Conclusion. VAD is increasingly being used as a bridge to heart transplantation in the pediatric population. Anesthesiologists must be vigilant about the pathophysiology of heart failure, the operative procedure, and the implanted device.en_US
dc.description.sponsorshipTurkish Transplantat Ctr Coordinat Assoc (TTCCA)en_US
dc.identifier.doi10.1016/j.transproceed.2013.02.068en_US
dc.identifier.endpage1012en_US
dc.identifier.issn0041-1345
dc.identifier.issue3en_US
dc.identifier.pmid23622610en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1009en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2013.02.068
dc.identifier.urihttps://hdl.handle.net/11454/47651
dc.identifier.volume45en_US
dc.identifier.wosWOS:000318457000042en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAnesthesia for Ventricular Assist Device Placement in Pediatric Patients: Experience From a Single Centeren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu